New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

It's normal for your eyes to change as you age, but these four expert-approved tips can help improve your eye health.

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they ...

Dr. Ali points out that historically, there haven’t been any advanced dry macular degeneration treatment options approved by the FDA. However, that changed in 2023. “The two FDA approved ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

"AlloVir and Kalaris enter merger to advance retinal disease therapies" was originally created and published by ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window GA lesions, which form on the retina due to degeneration of pigment epithelium and photoreceptors, significantly impact ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

in advanced dry age-related macular degeneration (AMD). With a mission to address significant unmet medical needs, Belite Bio is advancing its lead candidate, Tinlarebant, through various clinical ...

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...